Financials

  • Market Capitalization 423.7 M
  • Employee 73
  • Founded 2005
  • CEO Jason Okazaki
  • Website www.assemblybio.com
  • Headquarter Delaware, United States
  • FIGI BBG000R62Q06
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
346.88
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3015
EVMN
Evommune, Inc. Common Stock
12.26 USD+2.17%-6.27%-41.00%-29.21%441.59 M USD
3041
STRO
Sutro Biopharma, Inc. - Common Stock
26.04 USD+0.04%-18.55%-13.20%+49.74%431.49 M USD
3054
TENX
Tenax Therapeutics, Inc. - Common Stock
15.28 USD-1.80%-9.91%+32.87%+102.38%405.30 M USD
3056
PBYI
Puma Biotechnology Inc - Common Stock
8.34 USD+0.72%+3.35%+13.01%+134.93%424.50 M USD

Notizie